A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
Genentech, Inc.
Genentech, Inc.
National Cancer Institute (NCI)
Montefiore Medical Center
National Cancer Institute (NCI)
AbbVie
Travera Inc
OncoC4, Inc.
Jazz Pharmaceuticals
Exscientia AI Limited
USWM, LLC (dba US WorldMeds)
Seagen Inc.
Alliance for Clinical Trials in Oncology
Conjupro Biotherapeutics, Inc.
AstraZeneca
Amgen
Aulos Bioscience, Inc.
Arcus Biosciences, Inc.
Sotio Biotech Inc.
EMD Serono
GlaxoSmithKline
AstraZeneca
University of California, Irvine
Neonc Technologies, Inc.
ViroMissile, Inc.
Seagen Inc.
Merus B.V.
Pfizer
Arvinas Inc.
Tizona Therapeutics, Inc
Brigham and Women's Hospital
Poseida Therapeutics, Inc.
Baylor College of Medicine
MacroGenics
xCures
Daiichi Sankyo
One-carbon Therapeutics AB
SN BioScience
University of Nebraska
Takeda
Qilu Pharmaceutical Co., Ltd.
Zhejiang University
Adela, Inc
Perspective Therapeutics
Second Life Therapeutics
ImmunityBio, Inc.
Ocellaris Pharma, Inc.
Innate Pharma
Dren Bio
Var2 Pharmaceuticals
Inhibrx Biosciences, Inc